We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,668.50
Bid: 1,668.00
Ask: 1,669.00
Change: -1.50 (-0.09%)
Spread: 1.00 (0.06%)
Open: 1,661.50
High: 1,679.50
Low: 1,658.50
Prev. Close: 1,670.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London midday: Markets boosted by earnings, Eurozone PMIs

Wed, 24th Jul 2013 11:23

Upbeat corporate earnings from a number of heavyweights and improving data in the Eurozone gave UK markets a boost on Wednesday morning, as traders shrugged off concerns about manufacturing activity in China.easyJet, ARM Holdings, Tate & Lyle, Kingfisher and Compass were all trading firmly higher after results or trading updates this morning. Meanwhile, figures from blue chips Daimler, Volvo and Alstom also impressed over in Europe.In economic data, the Eurozone purchasing managers' indices (PMIs) for both the services and manufacturing sectors beat expectations in July, pushing the composite PMI from 48.7 to 50.4, well ahead of the 49.1 consensus forecast. This was the best reading of private-sector activity in 18 months."Sure, unemployment remains frighteningly high, political instability keeps the market on its toes and deep austerity will be biting hard for some time, but services and manufacturing facets of the Eurozone economy are turning a page," said Market Strategist Ishaq Siddiqi from ETX Capital.Markets were also digesting comments from Goldman Sachs analysts who said they see a near 50% probability that the Monetary Policy Committee will modify its stance at the August meeting. The most likely change would be a cut in the Bank rate or remuneration rate on bank reserves, but additional quantitative easing looks less likely. Chinese data disappointsHSBC's flash China manufacturing PMI fell from 48.2 to 47.7 in July, missing expectations of no change. "Under normal circumstances, this would weigh heavily on investor sentiment and therefore risk assets, such as the European indices, however that is not the case this morning," said Market Analyst Craig Erlam from Alpari.Downside risks to growth were tempered yesterday by the country's Premier Li Keqiang who assured that the pace of expansion would not fall below the "bottom line" of 7.0% this year, indicating that any slowdown would be met with more stimulus."This should limit the short-term negativity surrounding poor Chinese data because it seems for now that growth is guaranteed to remain at these higher levels," Erlam said.FTSE 100: Updates from heavyweights impresseasyJet surged this morning after the budget airline achieved a 10.5% rise in third-quarter revenue to £1.14bn, bolstered by an increase in capacity and growth in revenue per seat. Chip designer ARM Holdings was also on the rise after delivering better-than-expected second-quarter sales and profits. The company also said that dollar revenues would be "at least in line" with market expectations.Food ingredients firm Tate & Lyle gained after saying that adjusted profits were in line with expectations in spite of tough weather conditions in the States in the first quarter.Foodservice and support services company Compass rose after saying expectations for the full year remain "positive and unchanged" following a strong third quarter.Kingfisher, the DIY retail group behind B&Q and Screwfix, said it is on track to hit expectations for the first half after a pick-up in activity in the second quarter, causing shares to rise.Pharmaceuticals giant GlaxoSmithKline was trading higher this morning ahead of its results out this afternoon.Exchange operator London Stock Exchange was subdued after going ex-dividend. Engineering and project management group AMEC was trading lower after HSBC downgraded the stock to 'neutral' and cut its target price from 1,200p to 1,130p.FTSE 100 - RiserseasyJet (EZJ) 1,439.00p +7.71%ARM Holdings (ARM) 940.50p +4.73%Glencore Xstrata (GLEN) 292.40p +3.43%Weir Group (WEIR) 2,173.00p +2.89%Tate & Lyle (TATE) 847.00p +2.85%International Consolidated Airlines Group SA (CDI) (IAG) 293.90p +2.80%Travis Perkins (TPK) 1,720.00p +2.69%Antofagasta (ANTO) 875.50p +2.16%Melrose Industries (MRO) 273.60p +1.90%TUI Travel (TT.) 371.00p +1.87%FTSE 100 - FallersMeggitt (MGGT) 538.00p -1.65%Croda International (CRDA) 2,421.00p -1.14%British Land Co (BLND) 610.00p -1.13%BG Group (BG.) 1,198.00p -1.03%Sage Group (SGE) 356.00p -0.84%Hammerson (HMSO) 533.50p -0.56%Amec (AMEC) 1,066.00p -0.56%Hargreaves Lansdown (HL.) 1,006.00p -0.40%Barclays (BARC) 320.45p -0.40%Fresnillo (FRES) 1,088.00p -0.28%FTSE 250 - RisersImagination Technologies Group (IMG) 269.20p +7.38%Wetherspoon (J.D.) (JDW) 708.00p +5.99%National Express Group (NEX) 259.00p +5.50%Hochschild Mining (HOC) 171.60p +4.63%Mitchells & Butlers (MAB) 433.30p +4.41%Bumi (BUMI) 225.00p +3.93%Premier Farnell (PFL) 228.40p +3.12%Dialight (DIA) 1,221.00p +3.04%Playtech (PTEC) 706.50p +2.39%St. Modwen Properties (SMP) 308.80p +2.18%FTSE 250 - FallersBeazley (BEZ) 215.90p -4.34%TalkTalk Telecom Group (TALK) 246.80p -2.06%Renishaw (RSW) 1,535.00p -2.04%Kier Group (KIE) 1,395.00p -1.97%Man Group (EMG) 86.15p -1.94%Chemring Group (CHG) 301.00p -1.67%Carpetright (CPR) 666.00p -1.62%Great Portland Estates (GPOR) 577.50p -1.45%Anite (AIE) 130.00p -1.44%Barr (A.G.) (BAG) 562.00p -1.23%BC
More News
18 Dec 2023 07:18

GSK sees success in Jemperli endometrial cancer trial

(Sharecast News) - GSK released positive headline results from the planned analysis of its trial of Jemperli in endometrial cancer on Monday.

Read more
17 Dec 2023 15:16

PRESS: GSK looks for deals in China as rebuilds relationship

(Alliance News) - The Financial Times on Sunday reported that GSK PLC is looking for some new deals in China.

Read more
15 Dec 2023 17:08

European shares end fifth week higher on rate-cut optimism

Barclays sees first ECB rate cut in April

*

Read more
15 Dec 2023 16:51

LONDON MARKET CLOSE: FTSE 100 underperforms as post-Fed rally cools

(Alliance News) - London's FTSE 100 ended lower on Friday, with profit-taking and some hawkish words from a US policymaker keeping equities in check at the end of a largely positive week for stocks.

Read more
15 Dec 2023 16:29

PRESS: GSK, Astra and AbbVie in US scrutiny over patents - Bloomberg

(Alliance News) - A US senator has accused AstraZeneca PLC, GSK PLC, AbbVie Inc and other drugmakers of "abusing" the patent system to send prices higher, Bloomberg reported on Thursday.

Read more
12 Dec 2023 10:08

AstraZeneca buys respiratory vaccine developer Icosavax in $1.1 bln deal

Dec 12 (Reuters) - AstraZeneca said on Tuesday it had agreed to buy respiratory syncytial virus (RSV) vaccine developer Icosavax in a deal valued at up to $1.1 billion.

Read more
12 Dec 2023 08:22

TOP NEWS: Japan accepts GSK's filing for respiratory disease vaccine

(Alliance News) - GSK PLC on Tuesday said Japan's Ministry of Health, Labour & Welfare has accepted its regulatory application for the extension of its respiratory syncytial virus vaccine, Arexvy, for adults aged 50-59.

Read more
12 Dec 2023 07:39

LONDON BRIEFING: UK unemployment unchanged at 4.2%; eyes on US CPI

(Alliance News) - Stocks in London are called to open higher, as investors digest the latest UK unemployment data, before turning their heads to US inflation.

Read more
12 Dec 2023 07:24

GSK seeks to extend RSV vaccine approval in Japan

(Sharecast News) - GSK announced on Tuesday that Japan's Ministry of Health, Labour and Welfare (MHLW) has accepted its regulatory application for the extension of the indication of its RSV vaccine to include adults aged 50- to 59 at an increased risk of contracting the disease.

Read more
11 Dec 2023 08:28

GSK drug gets EU marketing backing for form of endometrial cancer

(Alliance News) - GSK PLC on Monday said it won EU backing for its Jemperli drug in tandem with chemotherapy to treat a form of endometrial cancer.

Read more
11 Dec 2023 07:41

LONDON BRIEFING: GSK drug gets EU endorsement; Begbies backs outlook

(Alliance News) - London's FTSE 100 is called to open a touch lower on Monday, kicking off the week with some slight trepidation after Friday's hotter-than-expected US jobs report which offered the dollar some respite.

Read more
11 Dec 2023 07:23

GSK endometrial cancer treatment gets Europe authorisation

(Sharecast News) - GSK announced on Monday that the European Commission has granted marketing authorisation for 'Jemperli', or dostarlimab, in combination with chemotherapy for certain endometrial cancers.

Read more
7 Dec 2023 12:54

THG backer Kelso pushes for demerger to trim "inherent" valuation gap

(Alliance News) - THG PLC investor Kelso Group Holdings PLC on Thursday reiterated its call for a demerger, which the shareholder believes will help close the "disparity" between the e-commerce firm's share price and its true value.

Read more
5 Dec 2023 10:02

LONDON BROKER RATINGS: Goldman lifts Landsec and British Land

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
27 Nov 2023 09:00

GSK announces positive results from Blenrep phase 3 blood cancer trial

(Alliance News) - GSK PLC on Monday said a phase 3 trial of belantamab mafodotin as a multiple myeloma treatment has produced positive headline results.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.